Clinical Trials Browser

INDUSTRY × Thymus Neoplasms × Nivolumab × Clear all

NCT03447470 2025-01-29

Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies

Phase 1 Completed

46 enrolled 29 charts

Gastrointestinal

Biliary Tract Neoplasms, Neoplasms, Thymus Neoplasms